tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Xenetic partner PeriNess enters clinical study agreement for XBIO-015
PremiumThe FlyXenetic partner PeriNess enters clinical study agreement for XBIO-015
4M ago
Xenetic: PeriNess in XBIO-015 study to treat osteosarcoma and Ewing sarcoma
Premium
The Fly
Xenetic: PeriNess in XBIO-015 study to treat osteosarcoma and Ewing sarcoma
4M ago
Xenetic reports FY24 EPS ($2.57)  vs. ($2.71) last year
Premium
The Fly
Xenetic reports FY24 EPS ($2.57) vs. ($2.71) last year
5M ago
Xenetic reports Q3 EPS (28c) vs. (69c) last year
PremiumThe FlyXenetic reports Q3 EPS (28c) vs. (69c) last year
9M ago
Xenetic presents preclinical data on DNase platform technology
Premium
The Fly
Xenetic presents preclinical data on DNase platform technology
9M ago
Xenetic Biosciences Expands Collaboration for Cancer Treatment
Premium
Company Announcements
Xenetic Biosciences Expands Collaboration for Cancer Treatment
9M ago
Xenetic reports Q2 EPS (83c) vs. (69c) last year
PremiumThe FlyXenetic reports Q2 EPS (83c) vs. (69c) last year
12M ago
XBIO Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
XBIO Upcoming Earnings Report: What to Expect?
12M ago
Xenetic Biosciences Announces Executive Leadership Restructuring
Premium
Company Announcements
Xenetic Biosciences Announces Executive Leadership Restructuring
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100